Matías J Alet: On the Implementation of Tenecteplase for Acute Ischemic Stroke at ESOC 2026
Matías J Alet, Member of Education Committee of World Stroke Organization, shared on LinkedIn:
”I was honored to participate in ESOC 2026 in Maastricht as part of the industry-sponsored satellite symposium ‘Opportunities for improving AIS patient outcomes’.
My talk, ‘Switching to TNK: the real-world experience’, focused on the implementation of tenecteplase for acute ischemic stroke, including international real-world evidence and early lessons from Argentina.
This transition is an opportunity to revisit hyperacute stroke workflows: simplifying administration, reducing treatment delays, improving transfer logistics, and strengthening local quality monitoring.
I am grateful to Boehringer Ingelheim for the invitation.
It was a privilege to share the Argentine perspective in such an important international forum.”
Stay updated with Hemostasis Today.
-
May 7, 2026, 07:21Britta Diebel: Reflections on Healthcare Impact from the PPTA IPPC Congress
-
May 7, 2026, 07:02Ana Cláudia de Souza: NeuroLeadership, Management and Behavioural Insights in Stroke Care from ESOC 2026
-
May 7, 2026, 07:00Maxime Dely: Just 60 Minutes of Our Time to Help a Patient We Will Never Meet
-
May 7, 2026, 06:37Anagha Kulkarni: Insights and A Prize from ISBMT Annual Conference 2026
-
May 7, 2026, 06:37Neelmani Singh: Why Iron Deficiency Is a Brain Health Issue
-
May 7, 2026, 06:25Vivek Sinha: The Science Behind a CBC Test
-
May 7, 2026, 06:17Emily Brown: Honor to Represent Hemophilia of Georgia at 2026 World Federation of Hemophilia Congress
-
May 7, 2026, 06:08Abdelaziz Fahem: INNOVHEM Reports a New Direct Method for Evaluating Hemolytic Anemia
-
May 7, 2026, 06:02Derick Rugenga: Every Person Living with Haemophilia Deserves to Live Without Fear